Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Automated radiosynthesis of [18F]DPA-714 on a commercially available IBA Synthera
Ist Teil von
Applied radiation and isotopes, 2024-05, Vol.207, p.111257-111257, Article 111257
Ort / Verlag
England: Elsevier Ltd
Erscheinungsjahr
2024
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
The goal of this work was to develop a reliable method to produce the well-validated microglial activation PET tracer, [18F]DPA-714, routinely for clinical and preclinical research using an IBA Synthera®. Optimization of literature methods included reduced precursor mass and use of TBA HCO3 as the phase transfer agent in place of Kryptofix® 222 in a 65-min synthesis with an average activity yield of 24.6 ± 3.8% (n = 5). Successful quality control testing and process validation results are reported.
•An IND-approved method for production of [18F]DPA-714 on an IBA Synthera® is reported.•Reduction of precursor mass and replacement of Kryptofix® 222 as phase transfer agent support production of tracer in reliable quantities for clinical research.•Justification of 5% injected ethanol in pediatric PET tracer preparations was outlined.